Huifan Yu

433 total citations
21 papers, 317 citations indexed

About

Huifan Yu is a scholar working on Molecular Biology, Nephrology and Pharmacology. According to data from OpenAlex, Huifan Yu has authored 21 papers receiving a total of 317 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 5 papers in Nephrology and 5 papers in Pharmacology. Recurrent topics in Huifan Yu's work include Pharmacological Effects of Natural Compounds (4 papers), Gout, Hyperuricemia, Uric Acid (4 papers) and Cancer Mechanisms and Therapy (2 papers). Huifan Yu is often cited by papers focused on Pharmacological Effects of Natural Compounds (4 papers), Gout, Hyperuricemia, Uric Acid (4 papers) and Cancer Mechanisms and Therapy (2 papers). Huifan Yu collaborates with scholars based in China and Australia. Huifan Yu's co-authors include Fei Li, Guangwen Shu, Jun Mu, Zhenpeng Qiu, Peng Cao, Cong Zhang, Mitchell A. Sullivan, Fei Li, Zhongshi Zhou and Hong Zhou and has published in prestigious journals such as Journal of Ethnopharmacology, European Journal of Pharmacology and International Journal of Biological Macromolecules.

In The Last Decade

Huifan Yu

21 papers receiving 316 citations

Peers

Huifan Yu
Ning Xue China
Chuangpeng Shen China
Jingru Ma China
Shu Dai China
Ying‐Kai Hong China
Xia Qiu China
Yeliu Fu China
Jiemei Li China
Hemat El‐Sayed El‐Horany Egypt
Ning Xue China
Huifan Yu
Citations per year, relative to Huifan Yu Huifan Yu (= 1×) peers Ning Xue

Countries citing papers authored by Huifan Yu

Since Specialization
Citations

This map shows the geographic impact of Huifan Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Huifan Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Huifan Yu more than expected).

Fields of papers citing papers by Huifan Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Huifan Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Huifan Yu. The network helps show where Huifan Yu may publish in the future.

Co-authorship network of co-authors of Huifan Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Huifan Yu. A scholar is included among the top collaborators of Huifan Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Huifan Yu. Huifan Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pan, Xianglin, et al.. (2025). Feasibility of galectin-3 as a diagnostic biomarker and therapeutic target for inflammatory bowel disease. European Journal of Pharmacology. 1005. 178041–178041. 1 indexed citations
2.
Zhang, Tao, Xiaofei Wang, Li Liu, et al.. (2025). Linarin attenuates hyperuricemic nephropathy by modulating Nrf2/Keap1 and TLR4/NF-κB signaling pathways. Phytomedicine. 139. 156440–156440. 7 indexed citations
3.
Cao, Wenjie, Linsheng Huang, Huifan Yu, et al.. (2025). Calycosin extracted from Astragali Radix reduces NETs formation to improve renal fibrosis via TLR4/NF-κB pathway. Journal of Ethnopharmacology. 342. 119391–119391. 3 indexed citations
4.
Wang, Junqing, Linsheng Huang, Huifan Yu, et al.. (2025). Role of Hippo-YAP/TAZ signaling pathway in organ fibrosis.. PubMed. 49(9). 1509–1516. 1 indexed citations
5.
6.
Yu, Huifan, et al.. (2024). Combined Hydroxyethyl Starch Luteolin Nanocrystals for Effective Anti-Hyperuricemia Effect in Mice Model. International Journal of Nanomedicine. Volume 19. 5139–5156. 6 indexed citations
7.
He, Haibo, Xiao Wang, Shu-Ran Zhang, et al.. (2024). Sweet triterpenoid glycoside from Cyclocarya paliurus ameliorates obesity-induced insulin resistance through inhibiting the TLR4/NF-κB/NLRP3 inflammatory pathway. Current Research in Food Science. 8. 100677–100677. 3 indexed citations
8.
Yu, Huifan, et al.. (2024). Luteolin ameliorates hyperuricemic nephropathy by activating urate excretion and Nrf2/HO‐1/NQO1 antioxidant pathways in mice. Food Science & Nutrition. 12(10). 8053–8066. 6 indexed citations
9.
10.
Cao, Peng, Sanlan Wu, Yixin Hu, et al.. (2023). Molecular mechanisms of hepatoprotective effect of tectorigenin against ANIT-induced cholestatic liver injury: Role of FXR and Nrf2 pathways. Food and Chemical Toxicology. 178. 113914–113914. 12 indexed citations
11.
Cao, Peng, Yì Wáng, Cong Zhang, et al.. (2023). Quercetin ameliorates nonalcoholic fatty liver disease (NAFLD) via the promotion of AMPK-mediated hepatic mitophagy. The Journal of Nutritional Biochemistry. 120. 109414–109414. 67 indexed citations
12.
13.
Cao, Peng, Ming Yue, Mitchell A. Sullivan, et al.. (2023). Naringenin prevents non‐alcoholic steatohepatitis by modulating the host metabolome and intestinal microbiome in MCD diet‐fed mice. Food Science & Nutrition. 11(12). 7826–7840. 23 indexed citations
14.
Meng, Jia, Fei Li, Huifan Yu, et al.. (2022). Ganoderma lucidumpolysaccharide peptide alleviates hyperuricemia by regulating adenosine deaminase and urate transporters. Food & Function. 13(24). 12619–12631. 45 indexed citations
15.
Nie, Bo, Yanting Wu, Hongliang Yao, et al.. (2021). Xanthomicrol suppresses human hepatocellular carcinoma cells migration and invasion ability via Μu-opioid receptor. Journal of Pharmacy and Pharmacology. 74(1). 139–146. 4 indexed citations
16.
Zhang, Cong, Junjie Hu, Yan Meng, et al.. (2021). Preparation, Characterization, and In Vitro Pharmacodynamics and Pharmacokinetics Evaluation of PEGylated Urolithin A Liposomes. AAPS PharmSciTech. 22(1). 26–26. 16 indexed citations
17.
18.
Zhang, Cong, Lei Sheng, Ming Yuan, et al.. (2020). Orlistat delays hepatocarcinogenesis in mice with hepatic co-activation of AKT and c-Met. Toxicology and Applied Pharmacology. 392. 114918–114918. 16 indexed citations
19.
Shu, Guangwen, et al.. (2018). Antitumor immunostimulatory activity of polysaccharides from Panax japonicus C. A. Mey: Roles of their effects on CD4 + T cells and tumor associated macrophages. International Journal of Biological Macromolecules. 111. 430–439. 54 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ning Xue Breakdown of academic impact, for papers by Chuangpeng Shen Breakdown of academic impact, for papers by Jingru Ma Breakdown of academic impact, for papers by Shu Dai Breakdown of academic impact, for papers by Ying‐Kai Hong Breakdown of academic impact, for papers by Xia Qiu Breakdown of academic impact, for papers by Yeliu Fu Breakdown of academic impact, for papers by Jiemei Li Breakdown of academic impact, for papers by Hemat El‐Sayed El‐Horany
Rankless by CCL
2026